148 related articles for article (PubMed ID: 35622386)
1. The bioinformatics and experimental analysis of the novel roles of virus infection-associated gene CDC20 for prognosis and immune infiltration in hepatocellular carcinoma.
Li J; Zhang X; Yao L; Hu K
Aging (Albany NY); 2022 May; 14(10):4513-4529. PubMed ID: 35622386
[TBL] [Abstract][Full Text] [Related]
2. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
3. CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.
Peng Q; Huang H; Zhu C; Hou Q; Wei S; Xiao Y; Zhang Z; Sun X
Oxid Med Cell Longev; 2022; 2022():8421813. PubMed ID: 36193067
[TBL] [Abstract][Full Text] [Related]
4. Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis.
Zhang X; Zhang X; Li X; Bao H; Li G; Li N; Li H; Dou J
Med Sci Monit; 2021 Mar; 27():e926760. PubMed ID: 33788826
[TBL] [Abstract][Full Text] [Related]
5. A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma.
Lai X; Wu YK; Hong GQ; Li JK; Luo Q; Yuan J; Dai GH; Liu SQ; Feng HG
J Immunol Res; 2022; 2022():9117205. PubMed ID: 35402624
[TBL] [Abstract][Full Text] [Related]
6. GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer.
Zheng Y; Shi Y; Yu S; Han Y; Kang K; Xu H; Gu H; Sang X; Chen Y; Wang J
Anal Cell Pathol (Amst); 2019; 2019():1038069. PubMed ID: 32082966
[TBL] [Abstract][Full Text] [Related]
7. Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma.
Li J; Gao JZ; Du JL; Huang ZX; Wei LX
Int J Oncol; 2014 Oct; 45(4):1547-55. PubMed ID: 25069850
[TBL] [Abstract][Full Text] [Related]
8. APC
Shi M; Dai WQ; Jia RR; Zhang QH; Wei J; Wang YG; Xiang SH; Liu B; Xu L
Cancer Lett; 2021 Jan; 496():144-155. PubMed ID: 33039559
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients.
Zhuang L; Yang Z; Meng Z
Biomed Res Int; 2018; 2018():7897346. PubMed ID: 30363964
[TBL] [Abstract][Full Text] [Related]
10. CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial‑mesenchymal transition.
Yang G; Wang G; Xiong Y; Sun J; Li W; Tang T; Li J
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33907851
[TBL] [Abstract][Full Text] [Related]
11. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphoma.
Sun C; Cheng X; Wang C; Wang X; Xia B; Zhang Y
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30393234
[TBL] [Abstract][Full Text] [Related]
13. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
[TBL] [Abstract][Full Text] [Related]
14. Prognostic evaluation and immune infiltration analysis of five bioinformatic selected genes in hepatocellular carcinoma.
Lai E; Tai Y; Jiang J; Zhao C; Xiao Y; Quan X; Wu H; Gao J
J Cell Mol Med; 2021 Dec; 25(24):11128-11141. PubMed ID: 34726341
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
16. Upregulated expression of
Li D; Ji Y; Guo J; Guo Q
Future Oncol; 2021 Aug; 17(24):3187-3201. PubMed ID: 34156259
[TBL] [Abstract][Full Text] [Related]
17. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
19. Low expression of moonlight gene ALAD is correlated with poor prognosis in hepatocellular carcinoma.
Ye Q; Yang X; Zheng S; Mao X; Shao Y; Xuan Z; Huang P
Gene; 2022 May; 825():146437. PubMed ID: 35318110
[TBL] [Abstract][Full Text] [Related]
20. Cell division cycle proteinising prognostic biomarker of breast cancer.
Cheng L; Huang YZ; Chen WX; Shi L; Li Z; Zhang X; Dai XY; Wei JF; Ding Q
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32285914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
